In This Section

Hosted by the ASPET Division for Drug Metabolism and Disposition (DMDD)

Wednesday, March 23, 2022, 12:00 pm – 1:00 pm ET

The DMDD Quarterly Webinar Series is intended to stimulate idea exchange and communication among DMDD members and to promote the career development of young scientists in the field of drug metabolism and disposition. Join us for this session where our featured junior scientists will discuss recent advancements in the pharmacology of equilibrative nucleoside transporters 1 and 2 and the assessment of metabolic biomarkers to assess drug response in cancer treatment.


Kerry Goralski, PhD, Dalhousie University


Nayiar Shahid, PhD Candidate, University of Alberta
Assessing the Impact of the Loss of Equilibrative Nucleoside Transporter (ENT) Subtype-1 on the Function and Pharmacology of ENT Subtype-2 using a Novel CRISPR-Cas9 HEK293-ENT1KO Cell Model 

Thomas Velenosi, PhD, University of British Columbia
Characterizing Metabolic Biomarkers of Drug Response using Patient-Derived Xenograft Cancer Models

Job Postings